EPIGENETIC VARIATION AT <i>SKA2</i> PREDICTS SUICIDE PHENOTYPES AND INTERNALIZING PSYCHOPATHOLOGY

Naomi Sadeh(University of Delaware), Mark W. Miller(Boston University), Mark W. Logue(Boston University), L. Michelle Griffin(Central Arkansas Veterans Healthcare System), Annjanette Stone(Central Arkansas Veterans Healthcare System), Erika J. Wolf(Boston University), Steven A. Schichman(Central Arkansas Veterans Healthcare System), Jasmeet P. Hayes(The Ohio State University)

Depression and Anxiety

April 1, 2016

10.1002/da.22480

Cited by 83

Related Papers

Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder

|JAMA|2022|195

High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

|Blood|2001|188

The Psychiatric Genomics Consortium Posttraumatic Stress Disorder Workgroup: Posttraumatic Stress Disorder Enters the Age of Large-Scale Genomic Collaboration

|Neuropsychopharmacology|2015|162

Accelerated DNA methylation age: Associations with PTSD and neural integrity

|Psychoneuroendocrinology|2015|152

Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data

|Cancer|2001|118